|
A Phase III Study Of Chemotherapy And Chemoradiotherapy With Or Without HyperAcute®-Pancreas (algenpantucel-L)Immunotherapy in Subjects With Surgically Resected Pancreatic Cancer
|
The purpose of this study is to determine the efficacy of giving subjects with pancreatic cancer the HyperAcute® Pancreas immunotherapy (experimental) along with chemotherapy and chemoradiation (standard). The study immunotherapy is made of two (2) genetically engineered human pancreatic cancer cell types. The purpose of this study is to compare the effects, good and/or bad, of standard of care therapy (gemcitabine alone or with chemoradiation) with or without the addition of HyperAcute®-Pancreas immunotherapy to find out which treatment is better.
|
Principal Investigator(s):
Francis W. Nugent, MD
For more information about this Research Study call 781-744-8027.
Study Coordinator(s):
Deborah J. Gannon.
|
|
Molecular Analysis of Cancer
|
The purpose of this research is to discover molecular changes involved in cancer. We hope that a better understanding of these changes can improve cancer management. This research may include genetic and/or genomic analysis (tests to determine and compare your genetic sequence, or DNA).
Some of the tissue we collect for our research may be submitted to the National Cancer Institute Cancer Genome Atlas Project. The goal of this project is to determine the genomic changes involved in more than 20 types of human cancer.
|
Principal Investigator(s):
Kimberly R. Christ, PhD
For more information about this Research Study call 781-744-8027.
Study Coordinator(s):
Doreen L. Browne, ,CCRP,
Jane S. Nalwalk,
Linda M. Topjian.
|